SGLT2 Inhibitor–Induced Euglycemic Diabetic Ketoacidosis: A Case Report

Euglycemic diabetic ketoacidosis is a rare but serious adverse effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors. We present a case of a woman in her 40s with type 2 diabetes mellitus hospitalized for revascularization for moyamoya disease who developed empagliflozin-associated euglycemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Katherine M., Isom, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380362/
https://www.ncbi.nlm.nih.gov/pubmed/32734242
http://dx.doi.org/10.1016/j.xkme.2019.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380362/
https://www.ncbi.nlm.nih.gov/pubmed/32734242
http://dx.doi.org/10.1016/j.xkme.2019.12.006

Ejemplares similares